PetMed Express Past Earnings Performance
Past criteria checks 0/6
PetMed Express's earnings have been declining at an average annual rate of -82.3%, while the Specialty Retail industry saw earnings declining at 2.8% annually. Revenues have been declining at an average rate of 7.1% per year.
Key information
-82.33%
Earnings growth rate
-82.18%
EPS growth rate
| Specialty Retail Industry Growth | 26.64% |
| Revenue growth rate | -7.07% |
| Return on equity | -197.98% |
| Net Margin | -34.70% |
| Last Earnings Update | 31 Dec 2025 |
Recent past performance updates
Recent updates
PETS: Rural King Partnership Will Shape Future Margins And Earnings Multiple
Analysts have trimmed their price target on PetMed Express to reflect a fair value update from $3.00 to $2.15 as they incorporate more moderate expectations for revenue contraction, profit margins, and a higher future P/E multiple into their models. What's in the News PetMed Express announced a partnership with Rural King to launch a new pet pharmacy offering across Rural King retail stores and digital platforms, expanding access to prescription medications, preventatives and pet health products for Rural King customers (Key Developments).Getting In Cheap On PetMed Express, Inc. (NASDAQ:PETS) Is Unlikely
It's not a stretch to say that PetMed Express, Inc.'s ( NASDAQ:PETS ) price-to-sales (or "P/S") ratio of 0.3x right now...Some Confidence Is Lacking In PetMed Express, Inc. (NASDAQ:PETS) As Shares Slide 26%
To the annoyance of some shareholders, PetMed Express, Inc. ( NASDAQ:PETS ) shares are down a considerable 26% in the...
Cost Cuts And Digital Upgrades Will Strain Future Margins
Optimism regarding savings from PetCareRx integration could jeopardize future profitability if anticipated savings do not materialize.PetMed Express: Dip Or Rip, A Buy After Earnings
Summary PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the bull case, and could, in fact, push this stock back down to "back up the truck" price levels. Conversely, even if PETS rallies on strong results, this may not capture all of the potential long-term upside. Even if it takes time to take shape, improvements in PetMed's operating performance could ultimately send the stock back to prices north of $15 per share. Read the full article on Seeking AlphaWe Think PetMed Express (NASDAQ:PETS) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Some PetMed Express, Inc. (NASDAQ:PETS) Shareholders Look For Exit As Shares Take 28% Pounding
PetMed Express, Inc. ( NASDAQ:PETS ) shares have retraced a considerable 28% in the last month, reversing a fair amount...PetMed Express: Why (And Why Not) The Rebound Could Continue
Summary PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turnaround continues. PetMed's management team is implementing a strategy change, not just cost-cutting measures, to continue improving the company's fiscal performance. Although many risks and uncertainties remain, given the outsized impact further improvements could have on the PETS stock price, at the very least add it to your watchlist. Read the full article on Seeking AlphaOptimistic Investors Push PetMed Express, Inc. (NASDAQ:PETS) Shares Up 28% But Growth Is Lacking
PetMed Express, Inc. ( NASDAQ:PETS ) shares have had a really impressive month, gaining 28% after a shaky period...PetMed Express, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
There's been a notable change in appetite for PetMed Express, Inc. ( NASDAQ:PETS ) shares in the week since its...PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates
PetMed Express, Inc. ( NASDAQ:PETS ) last week reported its latest annual results, which makes it a good time for...PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price
Key Insights Using the Dividend Discount Model, PetMed Express fair value estimate is US$7.95 Current share price of...A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Key Insights PetMed Express' estimated fair value is US$11.85 based on 2 Stage Free Cash Flow to Equity Current share...PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
The board of PetMed Express, Inc. ( NASDAQ:PETS ) has announced that it will pay a dividend of $0.30 per share on the...The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
PetMed Express, Inc. ( NASDAQ:PETS ) will pay a dividend of $0.30 on the 27th of February. This makes the dividend...Revenue & Expenses Breakdown
How PetMed Express makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 25 | 187 | -65 | 80 | 0 |
| 30 Sep 25 | 198 | -55 | 79 | 0 |
| 30 Jun 25 | 212 | -44 | 78 | 0 |
| 31 Mar 25 | 227 | -6 | 72 | 0 |
| 31 Dec 24 | 236 | 0 | 71 | 0 |
| 30 Sep 24 | 249 | -1 | 74 | 0 |
| 30 Jun 24 | 262 | -3 | 76 | 0 |
| 31 Mar 24 | 274 | -7 | 85 | 0 |
| 31 Dec 23 | 277 | -3 | 76 | 0 |
| 30 Sep 23 | 270 | -1 | 71 | 0 |
| 30 Jun 23 | 265 | 1 | 66 | 0 |
| 31 Mar 23 | 248 | 5 | 66 | 0 |
| 31 Dec 22 | 259 | 9 | 54 | 0 |
| 30 Sep 22 | 261 | 13 | 51 | 0 |
| 30 Jun 22 | 263 | 17 | 49 | 0 |
| 31 Mar 22 | 272 | 19 | 50 | 0 |
| 31 Dec 21 | 279 | 22 | 49 | 0 |
| 30 Sep 21 | 284 | 25 | 47 | 0 |
| 30 Jun 21 | 292 | 27 | 49 | 0 |
| 31 Mar 21 | 304 | 24 | 51 | 0 |
| 31 Dec 20 | 312 | 31 | 51 | 0 |
| 30 Sep 20 | 306 | 30 | 51 | 0 |
| 30 Jun 20 | 300 | 28 | 50 | 0 |
| 31 Mar 20 | 284 | 26 | 48 | 0 |
| 31 Dec 19 | 274 | 25 | 48 | 0 |
| 30 Sep 19 | 275 | 26 | 48 | 0 |
| 30 Jun 19 | 276 | 31 | 48 | 0 |
| 31 Mar 19 | 283 | 38 | 47 | 0 |
| 31 Dec 18 | 286 | 41 | 45 | 0 |
| 30 Sep 18 | 286 | 43 | 45 | 0 |
| 30 Jun 18 | 282 | 41 | 45 | 0 |
| 31 Mar 18 | 274 | 37 | 44 | 0 |
| 31 Dec 17 | 270 | 35 | 43 | 0 |
| 30 Sep 17 | 262 | 30 | 42 | 0 |
| 30 Jun 17 | 256 | 27 | 41 | 0 |
| 31 Mar 17 | 249 | 24 | 40 | 0 |
| 31 Dec 16 | 242 | 22 | 39 | 0 |
| 30 Sep 16 | 240 | 22 | 40 | 0 |
| 30 Jun 16 | 236 | 21 | 41 | 0 |
| 31 Mar 16 | 235 | 21 | 43 | 0 |
| 31 Dec 15 | 229 | 20 | 43 | 0 |
| 30 Sep 15 | 228 | 20 | 44 | 0 |
| 30 Jun 15 | 228 | 18 | 44 | 0 |
Quality Earnings: PETS is currently unprofitable.
Growing Profit Margin: PETS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PETS is unprofitable, and losses have increased over the past 5 years at a rate of 82.3% per year.
Accelerating Growth: Unable to compare PETS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PETS is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-2.1%).
Return on Equity
High ROE: PETS has a negative Return on Equity (-197.98%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 20:13 |
| End of Day Share Price | 2026/05/07 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PetMed Express, Inc. is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Erin Wilson Wright | BofA Global Research |
| Kristine Koerber | Citizens JMP Securities, LLC |
| David Westenberg | CL King & Associates, Inc. |